# Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients

> **NCT00928967** · — · COMPLETED · sponsor: **Bayer** · enrollment: 67 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon beta-1b, (Betaseron BAY86-5046)

## Key facts

- **NCT ID:** NCT00928967
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-11
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00928967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00928967, "Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00928967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*